Details for Patent: 11,827,646
✉ Email this page to a colleague
Which drugs does patent 11,827,646 protect, and when does it expire?
Patent 11,827,646 protects EVRYSDI and is included in one NDA.
This patent has fifty-two patent family members in thirty-five countries.
Drugs Protected by US Patent 11,827,646
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | 11,827,646 | ⤷ Subscribe | TREATMENT OF SPINAL MUSCULAR ATROPHY | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,827,646
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3143025 | ⤷ Subscribe | 301128 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3143025 | ⤷ Subscribe | PA2021010 | Lithuania | ⤷ Subscribe |
| European Patent Office | 3143025 | ⤷ Subscribe | 2021C/537 | Belgium | ⤷ Subscribe |
| European Patent Office | 3143025 | ⤷ Subscribe | CA 2021 00037 | Denmark | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
